Literature DB >> 8104850

Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines.

R C Ayres1, J M Neuberger, J Shaw, R Joplin, D H Adams.   

Abstract

Human intrahepatic biliary epithelial cells were isolated from the livers of patients with primary biliary cirrhosis and from normal livers and established in primary culture. The in vitro expression of intercellular adhesion molecule-1, HLA class I, and HLA class II on biliary epithelial cells was studied in response to tumour necrosis factor-alpha (0-500 U/ml), interferon-gamma (0-500 U/ml), and interleukin-1 (0-5 U/ml) by immunohistochemical staining and a semiquantitative scoring system validated by spectrophotometry and previously validated by laser confocal microscopy. The non-stimulated expression of intercellular adhesion molecule-1 and HLA class II was higher on cells derived from the primary biliary cirrhosis liver than on cells from normal liver, a difference not seen with HLA class I expression. A statistically significant increase in intercellular adhesion molecule-1 expression was seen with all three cytokines in cells derived from both primary biliary cirrhosis and normal liver. Increase in HLA class I expression was seen only with interleukin-1 5 U/ml for cells derived from both normal and diseased liver. Increase in HLA class II expression was seen only with interferon-gamma 500 U/ml for cells derived from diseased liver and with interleukin-1 5 U/ml for cells derived from both diseased and normal liver. These data show that pro-inflammatory cytokines increase expression of intercellular adhesion molecule-1, HLA class I, and HLA class II on human intrahepatic biliary epithelial cells in vitro and are consistent with the hypothesis that these locally acting factors may play a part in the pathogenesis of immune mediated disorders such as primary biliary cirrhosis in which immune mediated bile duct damage occurs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104850      PMCID: PMC1375463          DOI: 10.1136/gut.34.9.1245

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  Monoclonal antibodies against intercellular adhesion molecule 1 prolong cardiac allograft survival in cynomolgus monkeys.

Authors:  T Flavin; K Ivens; R Rothlein; R Faanes; C Clayberger; M Billingham; V A Starnes
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes.

Authors:  S L Saidman; R J Duquesnoy; A Zeevi; J J Fung; T E Starzl; A J Demetris
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

3.  Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis.

Authors:  S C Meuer; U Moebius; M M Manns; H P Dienes; G Ramadori; G Hess; T Hercend; K H Meyer zum Büschenfelde
Journal:  Eur J Immunol       Date:  1988-09       Impact factor: 5.532

4.  A 51Cr release cytotoxicity assay for use with human intrahepatic biliary epithelial cells.

Authors:  R C Ayres; J Shaw; C O Mills; R Coleman; J M Neuberger
Journal:  J Immunol Methods       Date:  1991-07-26       Impact factor: 2.303

Review 5.  The major histocompatibility complex--genetics and biology. (First of three parts).

Authors:  F H Bach; J J van Rood
Journal:  N Engl J Med       Date:  1976-10-07       Impact factor: 91.245

6.  Antigenic and immunogenic components in rat liver.

Authors:  I Lautenschlager; N Nyman; H Väänänen; V P Lehto; I Virtanen; P Häyry
Journal:  Scand J Immunol       Date:  1983-01       Impact factor: 3.487

7.  Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases.

Authors:  G R Pape; E P Rieber; J Eisenburg; R Hoffmann; C M Balch; G Paumgartner; G Riethmüller
Journal:  Gastroenterology       Date:  1983-09       Impact factor: 22.682

8.  Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  D H Adams; S G Hubscher; J Shaw; G D Johnson; C Babbs; R Rothlein; J M Neuberger
Journal:  Hepatology       Date:  1991-09       Impact factor: 17.425

9.  Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.

Authors:  H F Eggink; H J Houthoff; S Huitema; C H Gips; S Poppema
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

10.  Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody.

Authors:  C Barbatis; J Woods; J A Morton; K A Fleming; A McMichael; J O McGee
Journal:  Gut       Date:  1981-12       Impact factor: 23.059

View more
  33 in total

1.  Diagnostic approach to patients with cholestatic jaundice.

Authors:  N Assy; G Jacob; G Spira; Y Edoute
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

2.  Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage.

Authors:  E Giannini; F Botta; A Fasoli; P Romagnoli; L Mastracci; P Ceppa; I Comino; A Pasini; D Risso; R Testa
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

Review 3.  Role of cell adhesion molecules in leukocyte recruitment in the liver and gut.

Authors:  A Ala; A P Dhillon; H J Hodgson
Journal:  Int J Exp Pathol       Date:  2003-02       Impact factor: 1.925

Review 4.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

Review 5.  The immunobiology of cholangiocytes.

Authors:  Xian-Ming Chen; Steven P O'Hara; Nicholas F LaRusso
Journal:  Immunol Cell Biol       Date:  2008-05-27       Impact factor: 5.126

Review 6.  Advances in cholangiocyte immunobiology.

Authors:  Gaurav Syal; Michel Fausther; Jonathan A Dranoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-06       Impact factor: 4.052

Review 7.  Pathogenesis of primary biliary cirrhosis: a unifying model.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

8.  Gene-disease associations identify a connectome with shared molecular pathways in human cholangiopathies.

Authors:  Zhenhua Luo; Anil G Jegga; Jorge A Bezerra
Journal:  Hepatology       Date:  2018-01-02       Impact factor: 17.425

Review 9.  The immunology of primary biliary cirrhosis: the end of the beginning?

Authors:  J M Palmer; J A Kirby; D E J Jones
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

10.  Biliary epithelial apoptosis, autophagy, and senescence in primary biliary cirrhosis.

Authors:  Motoko Sasaki; Yasuni Nakanuma
Journal:  Hepat Res Treat       Date:  2010-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.